| GAFFX | LFGCX | GAFFX / LFGCX | |
| Total Expense Ratio | 0.29 | 1.80 | 16% |
| Annual Report Gross Expense Ratio | 0.29 | 1.99 | 15% |
| Fund Existence | 9 years | 7 years | - |
| Gain YTD | 9.046 | 8.302 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1500 | 66,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 357B | 169M | 211,243% |
| Annual Yield % from dividends | 0.51 | 0.00 | - |
| Returns for 1 year | 5.97 | 15.17 | 39% |
| Returns for 3 years | 46.06 | 100.38 | 46% |
| Returns for 5 years | 18.82 | 31.83 | 59% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGGIX | 12.68 | 0.05 | +0.40% |
| American Century Focused Global Gr I | |||
| VDIPX | 35.66 | 0.12 | +0.34% |
| Vanguard Developed Markets Index Ins Pls | |||
| RBAIX | 29.90 | 0.06 | +0.20% |
| T. Rowe Price Balanced I | |||
| IVITX | 22.69 | N/A | N/A |
| VY® Invesco Growth and Income S2 | |||
| PHSZX | 51.53 | -0.80 | -1.53% |
| PGIM Jennison Health Sciences Z | |||